In this activity, you will learn how different treatments can have profound effects on benign tissue and cancer morphology. This activity will also focus on the effects that radiation, androgen ablation, and other therapies have on prostate specimens so that you can make an effective decision regarding Gleason scoring.
After completing this activity, you should be able to:
- Define the effects that treatments, such as radiation and androgen ablation therapies, have on prostate cancer morphology.
- Describe how the effects of treatments impact Gleason score assignments.
Accreditation: The College of American Pathologists (CAP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CME Category 1: The College of American Pathologists designates this internet enduring material educational activity for a
maximum of 1
AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
You must answer the assessment questions and complete the evaluation to claim credit and print your certificate.
To pay with a check, print a copy of this page and send it with your check to the address below. You will be notified when your payment has been processed and you have been registered into the activity.
College of American Pathologists
325 Waukegan Road
Northfield, IL 60093-2750
Refunds will be handled on an exception basis. Please submit your request to the CAP in writing via email at
firstname.lastname@example.org or fax at 847-832-8006.
Pop-up blockers must be turned off.
CAP Learning has recognized that some Veteran’s Administration, US Government, and military participants may have difficulty accessing the online assessment portion of this activity. If you experience difficulty or have any questions, please contact a representative of the CAP Learning Division at 800-323-4040 option 1 or email@example.com.
This activity and evaluation are available November 8, 2021, and expire October 31, 2024, at 12:00 AM (ET). You must claim credit by this date and time.